2003Hebei yixueRequires access

The clinic efficacy of hydrotalcid and mosapride in treating bile reflux gastritis of 20 patients

AO Xiao-ming

Open publisher page 0 citations

Abstract

Objective: To evaluate the effect of hydrotalcid and mosapride in bile-reflux gastritis.Methods: Forty patients with bile-reflux gastritis by gastroscope examination were divided into 2 groups equally at random: T group 20 patients which were treated with hydrotalcid 1.0g, three times a day. T+M group 20 patients which were treated with hydrotacid and mosapride, mosapride 5.0mg, three times a day; hydrotalcid 1.0g ,three times a day. The change of the symptoms including abdominal pain, abdominal distention and bile vomitus were vestigated before and after four weeks treatment.Results: The severity of all the symptoms in the two groups decreased greaty after treatment(P0.01), the total effective rates was all 100%.Conclusions: Hydrotalcid can bind with intragastic bile, and effective decrease the symptoms of bile-reflux gastritis; Mosapride can reduce bile-reflux of duodenum. They are effective drugs in treating bile-reflux gastritis.

About this research paper

What this paper is about

Objective: To evaluate the effect of hydrotalcid and mosapride in bile-reflux gastritis.Methods: Forty patients with bile-reflux gastritis by gastroscope examination were divided into 2 groups equally at random: T group 20 patients which were treated with hydrotalcid 1.0g, three times a day. T+M group 20 patients which were treated with hydrotacid and mosapride, mosapride 5.0mg, three times a day; hydrotalcid 1.0g ,three times a day. The change of the symptoms including abdominal pain, abdominal distention and bile vomitus were vestigated before and after four weeks treatment.Results: The severity of all the symptoms in the two groups decreased greaty after treatment(P0.01), the total effective rates was all 100%.Conclusions: Hydrotalcid can bind with intragastic bile, and effective decrease the symptoms of bile-reflux gastritis; Mosapride can reduce bile-reflux of duodenum. They are effective drugs in treating bile-reflux gastritis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the effect of hydrotalcid and mosapride in bile-reflux gastritis.Methods: Forty patients with bile-reflux gastritis by gastroscope examination were divided into 2 groups equally at random: T group 20 patients which were treated with hydrotalcid 1.0g, three times a day. T+M group 20 patients which were treated with hydrotacid and mosapride, mosapride 5.0mg, three times a day; hydrotalcid 1.0g ,three times a day. The change of the symptoms including abdominal pain, abdominal distention and bile vomitus were vestigated before and after four weeks treatment.Results: The severity of all the symptoms in the two groups decreased greaty after treatment(P0.01), the total effective rates was all 100%.Conclusions: Hydrotalcid can bind with intragastic bile, and effective decrease the symptoms of bile-reflux gastritis; Mosapride can reduce bile-reflux of duodenum. They are effective drugs in treating bile-reflux gastritis.

Key concepts: Medicine, Mosapride, Gastroenterology, Bile reflux, Reflux, Internal medicine, Gastritis, Abdominal pain

Related papers

Back to paper searchBrowse research topicsOriginal source
The clinic efficacy of hydrotalcid and mosapride in treating bile reflux gastritis of 20 patients — Research Paper | ScholarLens